Manipal Heart Failure Registry (MHFR): A Long Term, Prospective and Descriptive Study of Heart Failure in a Tertiary Care Hospital in South India
试验速览
- 阶段
- 不适用
- 入组人数
- 500
- 试验地点
- 1
- 主要终点
- Prognosis of Heart Failure
研究概览
简要总结
Burden of HF in India is approximate 2-5 million patients with an estimated prevalence of 2-3/1000 population. HF is responsible for approx1.8 million admissions annually in India. Very few studies are there in India which shows the detailed documentation of HF.
Manipal Heart failure Registry (MHFR) is an institutional level Heart Failure disease registry. In MHFR the investigator will document the detailed information about heart failure patients admitted or referred to Department of Cardiology, Kasturba Medical College, a constituent college and teaching hospital of Manipal University.
MHFR will include cohorts of patients with acute heart failure (AHF), with the intention of implementing a long-term follow-up, the use of health economic assessment to evaluate the degree of resource utilization; and quantifying the burden on quality of life for patients. Utilization of drug in HF patients will be evaluated as a part of this study to prevent the use of inappropriate drug therapy and to improve overall drug effectiveness and outcomes. Hence the protocol sought to identify the characteristics and long-term outcomes of Indian patients with acute heart failure admitted in an Indian tertiary care center in South India.
There are no risks to patients participating in the registry study, as standard of care quality will not be affected. It is unlikely that there will be any direct benefit as a result of participation in the HF-disease registry. However, the information contained within this non-interventional registry study will be used for research studies directed at improving the knowledge and treatment of acute heart failure as well as improving patients treatment in the future.
The potential impact of proposed research (Manipal Heart Failure Registry) is envisioned to be four-fold:
- to enable a broad overview of the routine medical practices for HF treatment;
- to assess the healthcare resource utilization and drug utilization review for heart failure patients
- to assess the burden of disease (mortality, re-hospitalization) in the long term; and
- to provide a novel overview of the impact of HF syndrome on quality of life as well as health economics.
详细描述
RESEARCH GAPS IDENTIFIED:
Only a couple of registry studies in India have followed patients for not more than one year and therefore long-term data on disease management and healthcare resource utilization and health economics has never addressed adequately. Typically, these studies have focused primarily upon inpatient HF clinical profiles, where detailed long-term documentation of cardiac function, treatment patterns, and outcomes is lacking.
HYPOTHESES:
Long term follow up of heart failure patients can identify the disease characteristics, clinical outcomes and help in the development of a disease progression model, thereby eventually improving the practice standards. Proper utilization of healthcare resources decrease in-hospital and follow up mortality in heart failure patients.
The study team also hypothesize that the commonest cause of acute heart failure in our population in present era is myocardial infarction.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients 18 year old, and above
- •Patients with a documented diagnosis of Acute heart failure (or chronic heart failure with acute exacerbations) as decided by the physician according to local practices and their clinical judgment (i.e., History/examination; Chest X-ray; ECG, Echocardiogram, BNP or NT-proBNP).
排除标准
- •Patient's participation in any other clinical trial with an investigational treatment.
- •Use of investigational drugs within 5 half-lives of enrolment, or until the expected pharmacodynamic effect has returned to baseline, whichever is longer (as guideline, last dose for small molecules should have occurred more than 30 days, and for biologics more than 4 months prior to enrolment).
结局指标
主要结局
Prognosis of Heart Failure
时间窗: "through study completion, an average of 1 year"
Post discharge events are measured using symptoms and treatment outcomes assessment at follow up
Characterization of Heart failure
时间窗: "through study completion, an average of 1 year"
Characterization of HF is measured using in-hospital assessment at index hospitalization and discharge
次要结局
- Treatment Pattern("through study completion, an average of 1 year")
- Health care resources utilization("through study completion, an average of 1 year")
研究者
Ajit Singh, PhD
Principal Investigator
Manipal University